#USA #Cambrex #East Rutherford #Snapdragon Chemistry #Song Lin

Cambrex Honors Dr. Song Lin with 2025 Snapdragon Prize

Cambrex, a leading player in contract development and manufacturing for the pharmaceutical industry, has revealed that Dr. Song Lin, who holds the Tisch University Professorship in Chemistry and Chemical Biology at Cornell University, has been awarded the prestigious 2025 Snapdragon Prize for Innovation in Chemistry Technology. This accolade comes with a monetary award of $50,000 intended for Lin's lab to further his research initiatives.

Dr. Lin is recognized for his substantial contributions to electrosynthetic chemistry, a field that utilizes electrochemical processes to synthesize organic compounds. This new methodology has great implications for pharmaceutical development, promoting both efficiency and sustainability in producing complex organic molecules. His innovative techniques include sustainable electrochemical synthesis, particularly in creating chiral compounds essential for new pharmaceutical innovations.

Matthew Bio, Chief Scientific Officer of Cambrex, commented, "At Cambrex, we strive to push the boundaries of pharmaceutical science through innovation and partnerships. Professor Lin's exemplary work embodies the ideals of the Snapdragon Prize, aligning perfectly with our commitment to fostering transformative research that will redefine drug discovery and manufacturing."

Dr. Lin has an impressive array of accolades. He was recently recognized as a finalist for the 2025 Blavatnik National Awards, received the 2023 Arthur C. Cope Scholar Award, and was designated a 2025 Highly Cited Researcher by Clarivate. These achievements highlight his significant impact on the scientific community, particularly within the realms of sustainable chemistry and innovative research.

Established by Snapdragon Chemistry in 2024, the Snapdragon Prize seeks to honor a leading academic researcher each year in the fields of synthetic chemistry or engineering. This award is intended for individuals whose work may substantially influence pharmaceutical discovery and manufacturing processes. Past recipients include Princeton University’s Professor Todd Hyster, which sets a high standard for future awards and reflects Cambrex’s dedication to scientific excellence and innovation in developing complex small molecules.

About Cambrex
Cambrex operates as a global leader in contract development and manufacturing (CDMO), specializing in drug substance development and production throughout the entire lifecycle of drug manufacturing. With over 45 years of experience and a dedicated team of approximately 2,000 professionals servicing clients worldwide from North America and Europe, Cambrex is well-equipped with advanced knowledge across specialized drug substance technologies. These include continuous flow, controlled substances, peptide synthesis, solid-state science, material characterization, and highly potent active pharmaceutical ingredients (APIs).

Combining innovation and expertise, Cambrex continues to contribute significantly to the field of pharmaceuticals, ensuring future developments are not only groundbreaking but also environmentally responsible. Dr. Song Lin’s recognition through the Snapdragon Prize will undoubtedly propel forward not only his research but also the broader pharmaceutical landscape, reinforcing the critical relationship between academia and industry in driving future innovations.